| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:2793-2801.)
© 2007 American Heart Association, Inc.
Health Services and Outcomes Research |
From McMaster University, Hamilton, Canada (F.A.S.); University of Massachusetts Medical School, Worcester (F.A.S., J.M.G., R.J.G., G.F.); Cardiovascular Center, University of Michigan, Ann Arbor (M.M.); Duke University Medical Center, Durham, NC (C.B.G.); Hôpital Bichat-Claude Bernard, Paris, France (P.G.S.); Terrence Donnelly Heart Centre, St Michaels Hospital, University of Toronto, and Canadian Heart Research Centre, Toronto, Ontario, Canada (S.G.G.); Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); and Cardiovascular Research, University of Edinburgh, Edinburgh, Scotland (K.A.A.F.).
Correspondence to Dr Frederick A. Spencer, Department of Medicine, McMaster University, Faculty of Health Sciences, 1200 Main St W, Hamilton, Canada, L8N 3Z5. E-mail fspence{at}mcmaster.ca
Received February 5, 2007; accepted October 2, 2007.
Background— Analyses from randomized controlled trials suggest that bleeding in patients with acute myocardial infarction is associated with poor outcomes. Because these data are not generalizable to all patients with acute myocardial infarction, we sought to better understand the scope of this problem in a "real-world" setting.
Methods and Results— We examined the frequency of major bleeding in 40 087 patients with acute myocardial infarction enrolled in the Global Registry of Acute Coronary Events. Regression analyses were used to examine the association between patient and treatment characteristics, bleeding, and hospital and postdischarge outcomes. Major bleeding occurred in 2.8% of patients. These patients were older, more severely ill, and more likely to undergo invasive procedures. Patients with bleeding were more likely to die during hospitalization (hazard ratio, 1.9; 95% confidence interval, 1.6 to 2.2) but not after discharge (hazard ratio, 0.8; 95% confidence interval, 0.6 to 1.0) than patients who did not bleed. Continuation of antithrombotic therapies after day 1 was lower in patients who experienced early bleeding. Moreover, in patients who bled, hospital mortality was increased in those who discontinued aspirin, thienopyridines, or low–molecular-weight heparins.
Conclusions— Major bleeding occurred in 1 in 35 patients with acute myocardial infarction; these patients accounted for
10% of all hospital deaths. Nevertheless, risk of hospital mortality associated with bleeding was much lower than reported in randomized controlled trials. These data suggest that although bleeding may be causally related to adverse outcomes in some patients in the real-world setting, it is often merely a marker for patients at higher risk for adverse outcomes.
This article has been cited by other articles:
![]() |
J. W. Eikelboom, D. J. Quinlan, and M. O'Donnell Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials Circulation, November 17, 2009; 120(20): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Jolic{oelig}ur, W. W. O'Neill, A. Hellkamp, C. W. Hamm, D. R. Holmes Jr., H. R. Al-Khalidi, M. R. Patel, F. J. Van de Werf, K. Pieper, P. W. Armstrong, et al. Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Eur. Heart J., November 1, 2009; 30(21): 2575 - 2583. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Serebruany, S. V. Rao, M. A. Silva, J. L. Donovan, A. O. Kannan, L. Makarov, S. Goto, and D. Atar Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications Eur. Heart J., October 23, 2009; (2009) ehp434v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. van Hattum, A. Algra, J. A. Lawson, B. C. Eikelboom, F. L. Moll, and M. J.D. Tangelder Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease Circulation, October 20, 2009; 120(16): 1569 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ahmed, W. D. Piper, D. Malenka, P. VerLee, J. Robb, T. Ryan, M. Herne, W. Phillips, and H. L. Dauerman Significantly Improved Vascular Complications Among Women Undergoing Percutaneous Coronary Intervention: A Report From the Northern New England Percutaneous Coronary Intervention Registry Circ Cardiovasc Interv, October 1, 2009; 2(5): 423 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Doyle, C. S. Rihal, D. A. Gastineau, and D. R. Holmes Jr Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention implications for contemporary practice. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2019 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mehran, S. J. Pocock, G. W. Stone, T. C. Clayton, G. D. Dangas, F. Feit, S. V. Manoukian, E. Nikolsky, A. J. Lansky, A. Kirtane, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur. Heart J., June 2, 2009; 30(12): 1457 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Brieger, K A A Fox, G FitzGerald, K A Eagle, A Budaj, A Avezum, C B Granger, B Costa, F A Anderson Jr, P. G Steg, et al. Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events Heart, June 1, 2009; 95(11): 888 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Subherwal, R. G. Bach, A. Y. Chen, B. F. Gage, S. V. Rao, L. K. Newby, T. Y. Wang, W. B. Gibler, E. M. Ohman, M. T. Roe, et al. Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score Circulation, April 14, 2009; 119(14): 1873 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng, D. A. Morrow, S. Sloan, E. M. Antman, and M. S. Sabatine Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1195 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Budaj, J. W. Eikelboom, S. R. Mehta, R. Afzal, S. Chrolavicius, J.-P. Bassand, K. A.A. Fox, L. Wallentin, R. J.G. Peters, C. B. Granger, et al. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Eur. Heart J., March 2, 2009; 30(6): 655 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Shishehbor, S. Madhwal, V. Rajagopal, A. Hsu, P. Kelly, H. S. Gurm, S. R. Kapadia, M. S. Lauer, and E. J. Topol Impact of Blood Transfusion on Short- and Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 46 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Antoniucci The balance between bleeding and ischaemic complications in percutnaeous coronary intervention practice Eur. Heart J. Suppl., December 1, 2008; 10(suppl_J): J21 - J25. [Full Text] [PDF] |
||||
![]() |
R. P. Giugliano and E. Braunwald The Year in Non-ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., September 23, 2008; 52(13): 1095 - 1103. [Full Text] [PDF] |
||||
![]() |
D. A. Morrow Antithrombotic Therapy to Support Primary PCI N. Engl. J. Med., May 22, 2008; 358(21): 2280 - 2282. [Full Text] [PDF] |
||||
![]() |
What Is the Impact of Bleeding After Acute MI Treatment? Journal Watch Cardiology, February 6, 2008; 2008(206): 3 - 3. [Full Text] |
||||
![]() |
P. B. Berger and S. V. Manoukian Bleeding Is Bad.... Isn't It? Circulation, December 11, 2007; 116(24): 2776 - 2778. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |